Prot #GFT505-212-7: A Study to Evaluation the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients with Non-Alcoholic Steatohepatitis (NASH), A Multicenter, Randomized, Double Blind, Placebo-Controlled Study, with an Adaptive Design to

Project: Research project

Project Details

StatusFinished
Effective start/end date3/12/133/12/16

Funding

  • Premier Research International, LLC (Prot #GFT505-212-7)
  • Genfit SA (Prot #GFT505-212-7)